CVS Health (CVS) is having a standout 2025. While most of the market struggles, yesterday’s case in point, CVS is thriving, ...

CVS Health’s CVS stock has gained strong momentum so far in 2025, rising 47.1%. While operating income declined nearly 5% in ...

CVS Health Corp. will again have to defend itself before the US Court of Appeals for the First Circuit in litigation over concerns about its 2015 Omnicare Corp. acquisition—this time brought by an ...

We recently compiled a list of the 11 Oversold Blue Chip Stocks to Buy According to Hedge Funds. In this article, we are ...

虽然交易具体条款尚未公开，但此次收购标志着价值医疗领域的重要发展，可能影响全国Medicare患者的医疗管理和服务提供。本报道基于Wellvana的新闻稿。鉴于CVS Health年初至今46.41%的回报率和强劲的市场地位，投资者可通过 InvestingPro 的综合研究报告获取详细分析和10条额外独家建议。

根据美国证券交易委员会的Form 4文件显示，CVS健康 (NYSE: CVS )高级副总裁兼首席会计官James D. Clark于2025年3月5日以每股66.35美元的价格出售了7,513股普通股，总计498,487美元。目前CVS市值为837.7亿美元，年初至今的回报率达47.2%。根据 InvestingPro 分析，该股票目前交易价格低于其公允价值，13位分析师最近上调了其盈利预期。

CVS Pharmacy has announced plans to open a new kind of store in parts of the U.S. The pharmacy chain said it will open ...

CVS Health Corp. is discontinuing its Wellesley-based accountable care business, and will lay off 183 employees as it ...

CVS Health is on a mission to cut costs, and the insurer is turning toward its value-based care businesses as a solution, ...

The Woonsocket-based CVS (NYSE: CVS) said Tuesday that by selling its MSSP affiliated with CVS Accountable Care, it gains a ...

CVS sees 23% revenue growth in healthcare benefits & projects 10% EPS in 2025, with Aetna recovery boosting performance.